Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Toma

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 16, 2017
Decreased expression level of BER genes in Alzheimer's disease patients is not derivative of their DNA methylation statusAgnieszka Sliwinska, Przemysław Sitarek, Monika Toma, et al.
Oncotarget|October 6, 2016
PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomasMałgorzata Czyż, Monika Toma, Anna Gajos-Michniewicz, et al.
Leukemia|July 10, 2025
ADH5/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implicationsJessica Atkins, Anna-Mariya Kukuyan, Monika Toma, et al.
Blood|May 23, 2018
Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitorsSilvia Maifrede, Margaret Nieborowska-Skorska, Katherine Sullivan-Reed, et al.
Blood|December 29, 2022
DNA polymerase θ protects leukemia cells from metabolically induced DNA damageUmeshkumar Vekariya, Monika Toma, Margaret Nieborowska-Skorska, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 16, 2017
Decreased expression level of BER genes in Alzheimer's disease patients is not derivative of their DNA methylation statusAgnieszka Sliwinska, Przemysław Sitarek, Monika Toma, et al.
Oncotarget|October 6, 2016
PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomasMałgorzata Czyż, Monika Toma, Anna Gajos-Michniewicz, et al.
Leukemia|July 10, 2025
ADH5/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implicationsJessica Atkins, Anna-Mariya Kukuyan, Monika Toma, et al.
Blood|May 23, 2018
Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitorsSilvia Maifrede, Margaret Nieborowska-Skorska, Katherine Sullivan-Reed, et al.
Blood|December 29, 2022
DNA polymerase θ protects leukemia cells from metabolically induced DNA damageUmeshkumar Vekariya, Monika Toma, Margaret Nieborowska-Skorska, et al.
Pageof 4